Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NEIL H FELDMAN

Allopathic & Osteopathic Physicians Allergy & Immunology Allergy

NPI
1699742486
CMS profile
167213
Location
ALLENTOWN, PA

General Payments · PY2018–2024

$2,699.69

  • Reported across 146 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$798.50

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $798.50 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $337.72 15
Takeda Pharmaceuticals U.S.A., Inc. $115.36 4
GlaxoSmithKline, LLC. $89.32 4
CSL Behring $82.10 3
Amgen Inc. $64.66 3
PFIZER INC. $28.75 1
GENZYME CORPORATION $25.56 1
BioCryst US Sales Co., LLC $23.61 1
Genentech USA, Inc. $18.24 1
LEO Pharma Inc. $13.18 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $339.58 27
PY2019 $407.95 26
PY2020 $306.92 19
PY2021 $193.25 9
PY2022 $75.17 4
PY2023 $578.32 27
PY2024 $798.50 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $16.67 07/25/2024 Food and Beverage Undisputed 01/23/2026 1115618078 CMS
Amgen Inc. $24.97 08/21/2024 Food and Beverage Undisputed 01/23/2026 1115618086 CMS
Amgen Inc. $23.02 11/26/2024 Food and Beverage Undisputed 01/23/2026 1115618092 CMS
AstraZeneca Pharmaceuticals LP $19.53 01/03/2024 Food and Beverage Undisputed 01/23/2026 1104266423 CMS
AstraZeneca Pharmaceuticals LP $61.72 01/04/2024 Food and Beverage Undisputed 01/23/2026 1104627826 CMS
AstraZeneca Pharmaceuticals LP $17.03 02/01/2024 Food and Beverage Undisputed 01/23/2026 1104452780 CMS
AstraZeneca Pharmaceuticals LP $28.45 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105705908 CMS
AstraZeneca Pharmaceuticals LP $14.46 02/22/2024 Food and Beverage Undisputed 01/23/2026 1105473655 CMS
AstraZeneca Pharmaceuticals LP $14.54 03/13/2024 Food and Beverage Undisputed 01/23/2026 1104659205 CMS
AstraZeneca Pharmaceuticals LP $13.69 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105783176 CMS
AstraZeneca Pharmaceuticals LP $24.71 05/08/2024 Food and Beverage Undisputed 01/23/2026 1105711822 CMS
AstraZeneca Pharmaceuticals LP $16.11 05/29/2024 Food and Beverage Undisputed 01/23/2026 1104612512 CMS
AstraZeneca Pharmaceuticals LP $15.39 06/13/2024 Food and Beverage Undisputed 01/23/2026 1105649046 CMS
AstraZeneca Pharmaceuticals LP $21.48 08/06/2024 Food and Beverage Undisputed 01/23/2026 1105702206 CMS
AstraZeneca Pharmaceuticals LP $16.41 09/12/2024 Food and Beverage Undisputed 01/23/2026 1105810175 CMS
AstraZeneca Pharmaceuticals LP $24.21 10/15/2024 Food and Beverage Undisputed 01/23/2026 1105773888 CMS
AstraZeneca Pharmaceuticals LP $25.75 11/12/2024 Food and Beverage Undisputed 01/23/2026 1104610948 CMS
AstraZeneca Pharmaceuticals LP $24.24 12/09/2024 Food and Beverage Undisputed 01/23/2026 1105508540 CMS
BioCryst US Sales Co., LLC $23.61 02/16/2024 Food and Beverage Undisputed 01/23/2026 1117481498 CMS
CSL Behring $28.89 02/21/2024 Food and Beverage Undisputed 01/23/2026 1134634195 CMS
CSL Behring $24.19 06/12/2024 Food and Beverage Undisputed 01/23/2026 1134634287 CMS
CSL Behring $29.02 10/01/2024 Food and Beverage Undisputed 01/23/2026 1134634295 CMS
Genentech USA, Inc. $18.24 04/02/2024 Food and Beverage Undisputed 01/23/2026 1133080161 CMS
GENZYME CORPORATION $25.56 12/19/2024 Food and Beverage Undisputed 01/23/2026 1139623879 CMS
GlaxoSmithKline, LLC. $17.96 01/30/2024 Food and Beverage Undisputed 01/23/2026 1115954341 CMS
GlaxoSmithKline, LLC. $21.55 02/27/2024 Food and Beverage Undisputed 01/23/2026 1116621079 CMS
GlaxoSmithKline, LLC. $24.39 07/23/2024 Food and Beverage Undisputed 01/23/2026 1116642432 CMS
GlaxoSmithKline, LLC. $25.42 12/17/2024 Food and Beverage Undisputed 01/23/2026 1116284778 CMS
LEO Pharma Inc. $13.18 10/29/2024 Food and Beverage Undisputed 01/23/2026 1152629557 CMS
PFIZER INC. $28.75 01/12/2024 Food and Beverage Undisputed 01/23/2026 1130976860 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.01 01/25/2024 Food and Beverage Undisputed 01/23/2026 1137545192 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.68 08/13/2024 Food and Beverage Undisputed 01/23/2026 1137545196 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.62 09/25/2024 Food and Beverage Undisputed 01/23/2026 1137545200 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.05 10/08/2024 Food and Beverage Undisputed 01/23/2026 1137545204 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.